Cosmos Health Inc. logo

COSMCosmos Health Inc.

NASDAQ · Healthcare · Medical Distribution

$0.23

+$0.00 (+1.58%)

Cosmos Health Inc. (COSM) is a medical distribution company listed on NASDAQ. It is led by Grigorios Siokas, based in 141 West Jackson Boulevard, Chicago, IL, United States, 60604, with about 149 employees. Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus. The company offers medicines, OTC medicines, nutraceutical products, vitamins, minerals, and dietary health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names. Other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag to promote peaceful sleep; Otikon ear drops, which is a Class II medical device in the form of ear drops; and Bio-bebe, an organic infant care and nutrition brand. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies, and independent specialty distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Latest reported COSM revenue for 2026-06-30 was $19.0M. Net income was -$6.1M. Revenue was up 5.9% from 2026-03-31 to 2026-06-30. COSM currently screens at market cap $13.5M.

Use this COSM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the COSM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the COSM SEC filings page. Lician reads the product cache first so this HTML stays unique to Cosmos Health Inc. even when a live quote feed is slow.

About Cosmos Health Inc.

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus. The company offers medicines, OTC medicines, nutraceutical products, vitamins, minerals, and dietary health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names. Other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag to promote peaceful sleep; Otikon ear drops, which is a Class II medical device in the form of ear drops; and Bio-bebe, an organic infant care and nutrition brand. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies, and independent specialty distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

COSM Key Statistics

Market Cap

$13.45M

Volume

1.03M

Previous Close

$0.21

Day Range

$0.20$0.21

00

EPS

-$0.63

Revenue

$65.27M

Net Income

-$19.14M

Gross Profit

$7.90M

Free Cash Flow

-$8.39M

Revenue Growth

+19.9%

Profit Margin

-29.3%

Debt to Equity

0.00

Employees

149

COSM Financials

Annual income statement in USD. Latest reported periods first.

COSM annual income statement across FY2025, FY2024
LineFY2025FY2024
Revenue$65.27M$54.43M
Cost of Revenue$57.38M$50.12M
Gross Profit$7.90M$4.31M
Operating Income-$16.70M-$15.54M
Net Income-$19.14M-$16.18M
EPS (Diluted)-$0.63-$1.17

Total Assets

$65.48M

Total Debt

$0.00

Shareholders' Equity

$18.42M

Cash & Equivalents

$715.67K

Operating Cash Flow

-$8.45M

Free Cash Flow

-$8.39M

Cosmos Health Inc. Company Information

Chairman & CEO
Grigorios Siokas
Headquarters
141 West Jackson Boulevard, Chicago, IL, United States, 60604
Phone
312 536 3102
IPO / Founded
2012-10-11
Industry
Medical Distribution
Data Updated:

Upcoming Events for COSM